Dr. Falk PharmaFalk Foundation
  • About us
    About us
    • Now into the future
    • Innovation drives everything
    • Why we are
    • Global presence
  • Indications
    Indications
    • Crohn’s Disease
    • Eosinophilic Oesophagitis
    • Primary Biliary Cholangitis
    • Ulcerative colitis
  • Our products
  • News
  • Education centre
Search
Please choose your country
  • Global (English)
  • Australia
  • België (Vlaams)
  • Belgique (Français)
  • Deutschland
  • España
  • France
  • Ireland
  • Italia
  • Luxembourg (Français)
  • Nederland
  • Österreich
  • Portugal
  • Россия
  • Schweiz (Deutsch)
  • Suisse (Français)
  • United Kingdom
more info

Contact:
Phone:1800 DRFALK (1800 373 255)Email:admin@drfalkpharma.com.au

    • About us
    • Search
    • Contact
    • Falk Foundation
    • For Healthcare Professionals
    • Reporting adverse events
    HCP Portal
    • About us
      • Now into the future
      • Innovation drives everything
      • Why we are
      • Global presence
    • Indications
      • Crohn’s Disease
      • Eosinophilic Oesophagitis
      • Primary Biliary Cholangitis
      • Ulcerative colitis
    • Our products
    • News
    • Education centre
      • About us
      • Search
      • Contact
      • Falk Foundation
      • For Healthcare Professionals
      • Reporting adverse events
      Contact:
      Phone:
      1800 DRFALK (1800 373 255)
      Email:
      admin@drfalkpharma.com.au
      • Homepage
      • Search

      Search results

      34 results

      • 1
      • 2
      • 3
      • 4
      • 5
      • »
      • Crohn’s Disease
        Crohn’s Disease Homepage Indications Crohn’s Disease Crohn’s Disease Crohn’s disease belongs to the group of disorders known as inflammatory bowel disease. Definition A diagnosis of “Crohn’s disease”…
      • Primary Biliary Cholangitis
        Primary Biliary Cholangitis Homepage Indications Primary Biliary Cholangitis Primary Biliary Cholangitis Primary biliary cholangitis (PBC) is a chronic autoimmune disease of the small bile ducts in…
      • Eosinophilic Oesophagitis
        Eosinophilic Oesophagitis Homepage Indications Eosinophilic Oesophagitis Eosinophilic Oesophagitis Eosinophilic oesophagitis (abbreviated EoE) is a condition characterised by chronic inflammation of…
      • Indications
        Indications Homepage Indications Indications The following pages provide in-depth information about chronic diseases of the intestines, oesophagus, and bile ducts. Crohn’s Disease Crohn’s disease is…
      • Global presence
        Global presence Austria Dr. Falk Pharma Österreich GmbH Wolfgang-Pauli-Gasse 5 1140 Wien Phone: +43 1 577 35 16 0 Fax: +43 1 577 35 16 20 Email: info[at]drfalkpharma.at Web:…
      • Why we are
        Why we are Homepage About us Why we are Why we are It always starts with an idea The idea of Dr. Herbert Falk is "Progress through interaction" in the field of gastroenterology and hepatology.…
      • Medium
        Salofalk enema
      • 1
      • 2
      • 3
      • 4
      • 5
      • »
      Falk Foundation

      Discover the range of continuing education opportunities for physicians and pharmacists provided by the Falk Foundation e.V.

      Dr. Falk Pharma Australia

      Dr. Falk Pharma Australia is the expert in digestive and metabolic medicine. As a research-based family business with global presence, we focus on the development and distribution of innovative medicines that improve patients’ health and well-being. 

      • Falk Foundation
      • For Healthcare Professionals
      • Reporting adverse events
      • Crohn’s Disease
      • Eosinophilic Oesophagitis
      • Primary Biliary Cholangitis
      • Ulcerative colitis
      © 2023 Dr. Falk Pharma Australia
      • Terms & conditions of use
      Notice

      This website is an international information resource intended for healthcare professionals outside the United States (US) and United Kingdom (UK).

      I am a health care professional outside the US and UK.

      Accept

      You are leaving the website of Dr. Falk Pharma in Australia.

      We are not liable for the accuracy of any content published on third party websites – such as the one you are about to be forwarded to.